JOHN JAMES: Open Payments
NPI 1992454425 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$157 in 8 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $157
Food & beverage: $157
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $45 |
| Lilly USA, LLC | 2 | $31 |
| Life Molecular Imaging Ltd | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Amgen Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $14 |
Products named: UBRELVY, NEURACEQ, AREXVY, QULIPTA, MOUNJARO, EVENITY, Rybelsus, KISUNLA.
Industry payments across UT — which companies pay providers there.
